Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009.

Vernon J. Lee,Jonathan Yap,Joshua K. Tay,Ian G. Barr,Qiuhan Gao,Hanley J. Ho,Boon Huan Tan,Paul Kelly,Paul A. Tambyah,Anne Kelso,Mark I-Cheng Chen

Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009.

2010

Vernon J. Lee
Jonathan Yap
Joshua K. Tay
Ian G. Barr
Qiuhan Gao
Hanley J. Ho
Boon Huan Tan
Paul Kelly
Paul A. Tambyah
Anne Kelso
Mark I-Cheng Chen

Background Anti-viral prophylaxis is used to prevent the transmission of influenza. We studied serological confirmation of 2009 Influenza A (H1N1) infections during oseltamivir prophylaxis and after cessation of prophylaxis.

Keywords:

Chemoprophylaxis
Virology
Pathology
Oseltamivir
Asymptomatic
Seroconversion
Medical microbiology
Prevalence
Medicine
Post-exposure prophylaxis
Adverse effect
Pandemic

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations